Details of the Drug Reposition

General Information of This Drug (ID: DMR0EWV)

Drug Name
SAR342434   DMR0EWV

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-1 diabetes DIS7HLUB 5A10 Phase 3 [1]
Type-2 diabetes DIS3X247 5A11 Phase 3 [1]
Diabetic complication DIS4S2FC 5A2Y Phase 3 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02273180) Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine. U.S. National Institutes of Health.